In contrast; Zheng et al., (2016); El-Ghany et al., (2014) studied the SDF-1 G801A polymorphism in 466 and 48 adult de novo AML patients respectively, reported no significant difference in genotype distributions and allele frequency between AML patients and healthy controls. The gene discussed is CXCL12; the disease is acute myeloid leukemia.